Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart
6 Months : From Oct 2019 to Apr 2020
By Josh Beckerman
Pacific Biosciences of California Inc. (PACB) shares fell 9% after hours to $4.85 as the Federal Trade Commission said it is challenging the company's $1.2 billion sale to Illumina Inc. (ILMN).
The deal was disclosed in November 2018. In January, Pacific Biosciences said the FTC requested additional information on the transaction.
Write to Josh Beckerman at email@example.com
(END) Dow Jones Newswires
December 17, 2019 17:17 ET (22:17 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.